The current study found a significant downregulation of insulin receptor, IRS-1, and IRS-3 genes expression in skeletal muscles with induced diabetes while treatment with either telmisartan or metformin significantly enhanced their expression. This evidence concerns the gene IRS1 and diabetes mellitus.